Majem M, Álvarez R, Ortega AL, Ruiz de Alda L, Gordo R, García JF, Ivanova-Markova Y, González-Domínguez A, Sánchez San Cristóbal R, Rojo F. Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain. Grhta [Internet]. 2022 Sep. 12 [cited 2024 Nov. 21];9(1):82-90. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2449